sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
2-Aug-2015 22:48
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 101-125 out of 1084.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>

Public Release: 8-Jun-2015
Vanderbilt University receives Grand Challenges Explorations Grant
Vanderbilt biologist Laurence Zwiebel has received a Gates Foundation Grand Challenges Exploration grant to create a wrist-band device that vaporizes a super-repellant thousands of times more powerful than DEET to create a personal no-fly zone that protects people from mosquitoes and other disease-carrying insects.
Gates Foundation

Contact: David Salisbury
david.salisbury@vanderbilt.edu
615-343-6803
Vanderbilt University

Public Release: 8-Jun-2015
Journal of Clinical Oncology
Important new research on early palliative care for advanced cancer patients published
Researchers at Trinity College Dublin and Mount Sinai in New York have just published new research which for the first time provides strong evidence on the economic benefits of early palliative care intervention for people with an advanced cancer diagnosis. Their findings were published today in the highly esteemed international peer-reviewed Journal of Clinical Oncology.

Contact: Yolanda Kennedy
yokenned@tcd.ie
353-189-63551
Trinity College Dublin

Public Release: 8-Jun-2015
Malaria Journal
Modern housing reduces malaria risk
As mosquitoes become resistant to insecticides and malaria parasites become resistant to drugs, researchers looked at how making changes to houses might contribute to tackling the deadly disease. They revealed that people living in modern homes were 47 percent less likely to be infected with malaria than those living in traditional houses, which suggests that housing is an important risk factor for malaria.
Leverhulme Centre for Integrative Research in Agriculture and Health, National Institutes of Health, Bill & Melinda Gates Foundation, Novartis Foundation for Sustainable Development, Medical Research Council, Department for International Development

Contact: Katie Steels
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Public Release: 8-Jun-2015
The Lancet
As death rates drop, nonfatal diseases and injuries take a bigger toll on health globally
People across the world are living longer but spending more time in ill health as rates of nonfatal diseases and injuries -- including diabetes and hearing loss -- decline more slowly than death rates, according to a new analysis of 301 diseases and injuries in 188 countries.

Contact: Rhonda Stewart
stewartr@uw.edu
206-897-2863
Institute for Health Metrics and Evaluation

Public Release: 8-Jun-2015
Journal of Clinical Investigation
Antibody response linked to lower mother-to-child HIV transmission
How most babies are protected from acquiring HIV from their infected mothers has been a matter of scientific controversy. Now researchers at Duke Medicine provide new data identifying an antibody response that had long been discounted as inadequate to confer protection.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 8-Jun-2015
Nature
Virus evolution and human behavior shape global patterns of flu movement
The global movement patterns of all four seasonal influenza viruses are illustrated in research published today in the journal Nature, providing a detailed account of country-to-country virus spread over the last decade and revealing unexpected differences in circulation patterns between viruses.
Royal Society, US National Institutes of Health

Contact: Craig Brierley
craig.brierley@admin.cam.ac.uk
44-012-237-66205
University of Cambridge

Public Release: 5-Jun-2015
Diabetes Technology & Therapeutics
More accurate continuous glucose monitoring systems can reduce frequency of hypoglycemic episodes
In silico experiments demonstrate that advanced sensor and software technology that improves the accuracy of Continuous Glucose Monitoring (CGM) can enable better detection of dangerously low blood sugar and reduced frequency of hypoglycemic episodes. The significance of this direct relationship between the accuracy of CGM and a reduction in hypoglycemia is explored in a Commentary published in Diabetes Technology & Therapeutics.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 4-Jun-2015
Warren Alpert Foundation Prize recognizes malaria breakthroughs
The 2015 Warren Alpert Foundation Prize will be awarded to Ruth S. Nussenzweig and Victor Nussenzweig, both faculty at the NYU Langone Medical Center, and Tu Youyou of the China Academy of Chinese Medical Sciences, Beijing, for their pioneering discoveries in chemistry and parasitology, and their personal commitment to translating these discoveries into effective chemotherapeutic and vaccine-based approaches to controlling malaria.
Warren Alpert Foundation

Contact: David Cameron
david_cameron@hms.harvard.edu
617-432-0441
Harvard Medical School

Public Release: 4-Jun-2015
Child-friendly formulation of WHO-recommended HIV treatment approved by US FDA
Infants and young children living with HIV will finally have access to an improved formulation of an antiretroviral treatment, following the US Food and Drug Administration's tentative approval last week of lopinavir/ritonavir oral pellets developed by the Indian generic company Cipla.

Contact: Sian Bowen
sbowen@dndi.org
41-229-069-247
Drugs for Neglected Diseases Initiative

Public Release: 4-Jun-2015
PLOS Pathogens
Cozy niches: Certain host cell environments make malaria parasites resistant to drugs
A study published on June 4 in PLOS Pathogens shows that the different metabolic states of human host cells provide different growth conditions for Plasmodium parasites. It warns that, as a consequence, drugs that work against one Plasmodium species might fail to be effective against the other.

Contact: Andy Waters
Andy.Waters@glasgow.ac.uk
44-014-133-08720
PLOS

Public Release: 2-Jun-2015
Cell Host & Microbe
Immunity enzyme defends against tuberculosis infection, study by UTSW scientists shows
A study by researchers at UT Southwestern Medical Center has identified how an enzyme involved in protecting the body from pathogens senses Mycobacterium tuberculosis, a bacterial pathogen that infects millions of people worldwide and causes about 1.5 million deaths annually.
National Institutes of Health, Cancer Prevention and Research Institute of Texas, and Howard Hughes Medical Institute

Contact: Debbie Bolles
debbie.bolles@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

Public Release: 2-Jun-2015
Placental malaria research funded by March of Dimes
The March of Dimes Foundation, an American organization that works to improve pregnancy and baby health, has now funded Carlos Penha-Goncalves' laboratory, at the Instituto Gulbenkian de Ciencia, for their studies on factors and mechanisms involved in placental malaria. This is the first time that this American Foundation funds research from a Portuguese Institution.
March of Dimes Foundation

Contact: Ana Mena
anamena@igc.gulbenkian.pt
351-214-407-959
Instituto Gulbenkian de Ciencia

Public Release: 2-Jun-2015
DNDi and 4 pharmaceutical companies announce 'drug discovery booster' experiment
DNDi and four pharmaceutical firms, Eisai Co Ltd., Shionogi & Co Ltd., Takeda Pharmaceutical Ltd., and AstraZeneca plc have announced the start of a ground-breaking initiative to accelerate and cut the cost of early stage drug discovery for two of the world's most neglected diseases, leishmaniasis and Chagas disease.

Contact: Sian Bowen
sbowen@dndi.org
41-229-069-247
Drugs for Neglected Diseases Initiative

Public Release: 2-Jun-2015
Proceedings of the National Academy of Sciences
Researchers discover two new groups of viruses
Researchers at the University of Bonn and the German Center for Infection Research have discovered two new groups of viruses within the Bunyavirus family in the tropical forest of Ivory Coast. Previously only five groups responsible for serious illnesses in humans and animals were known. Most are spread through blood-feeding insects. Based on the discovered viruses researchers conclude that the ancester to all bunyaviruses must have existed in arthropods such as insects.

Contact: Sandra Junglen
Junglen@virology-bonn.de
49-022-828-713-068
University of Bonn

Public Release: 2-Jun-2015
The Lancet Psychiatry
Study shows helping pregnant moms with depression doesn't help kids
A long-term study of mother-child pairs in Pakistan has found that the children turn out pretty much the same, whether or not their mothers received treatment for depression during pregnancy. An earlier study of the same population found that the mothers themselves benefited from the treatment with less depression, and demonstrating related healthy behaviors with their newborns, such as breastfeeding. But those improvements were short-lived.
Grand Challenges Canada

Contact: Diana Harvey
Diana.Harvey@Duke.edu
919-681-7718
Duke University

Public Release: 2-Jun-2015
Cell, Host & Microbe
How the tuberculosis bacterium tricks the immune system
Scientists at EPFL have discovered how the tuberculosis bacterium can trick the patient's immune cells to lower their defenses.
Swiss National Science Foundation

Contact: Nik Papageorgiou
n.papageorgiou@epfl.ch
41-216-932-105
Ecole Polytechnique Fédérale de Lausanne

Public Release: 1-Jun-2015
American Journal of Human Biology
Cannabis use in male African pygmies linked to decreased risk of parasitic worm infection
In a population of Congo Basin foragers called the Aka, 67 percent of men -- but only 6 percent of women -- use cannabis, and the practice seems to protect against infection with parasitic worms.

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley

Public Release: 1-Jun-2015
American Journal of Human Biology
WSU researchers see link between hunter-gatherer cannabis use, fewer parasites
Washington State University researchers have found that the more hunter-gatherers smoke cannabis, the less they are infected by intestinal worms. The link suggests that they may unconsciously be, in effect, smoking medical marijuana.
State of Washington

Contact: Ed Hagen
edhagen@wsu.edu
360-546-9257
Washington State University

Public Release: 1-Jun-2015
Journal of Immunology
Researchers create new combination vaccine to fight Streptococcus A
Griffith University's Institute for Glycomics has developed a groundbreaking, combination vaccine that may finally beat Streptococcus A infections. Human trials are set to begin, early as next year, for the vaccine which combines the protein, SpyCEP, with a previously developed vaccine J8-DT.

Contact: Melinda Rogers
melinda.rogers@griffith.edu.au
047-849-4898
Griffith University

Public Release: 29-May-2015
American Academy of Neurology 2015 Annual Meeting
CHOP global health focuses on children with cerebral palsy in southern Africa
Cerebral palsy is the most common cause of childhood disability in the world, but is understudied, especially in developing countries. Working in Botswana, an ongoing international partnership has performed the first rigorous study of CP outcomes in Africa.
National Institutes of Health, International Child Neurology Association, University of Pennsylvania Center for AIDS Research

Contact: Natalie Virgilio
Virgilion@email.chop.edu
267-426-6246
Children's Hospital of Philadelphia

Public Release: 28-May-2015
JAMA Oncology
New cancer cases rise globally, but death rates are declining in many countries
New cases of virtually all types of cancer are rising in countries globally -- regardless of income -- but the death rates from cancer are falling in many countries, according to a new analysis of 28 cancer groups in 188 countries.

Contact: Rhonda Stewart
stewartr@uw.edu
206-897-2863
Institute for Health Metrics and Evaluation

Public Release: 28-May-2015
PLOS Pathogens
New findings shed light on complexities of emerging zoonotic malaria
Zoonotic malaria has been shown to be caused by two genetically distinct Plasmodium knowlesi parasite subpopulations associated with different monkey host species in Malaysia, according to new research led by the London School of Hygiene & Tropical Medicine. The authors believe this could have important implications for how the parasite adapts and spreads in humans.
Medical Research Council UK, University of Malaysia Sarawak

Contact: Jenny Orton
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Public Release: 28-May-2015
Cell Host & Microbe
Controlling typhoid bacterium key to prevent gallbladder cancer in India and Pakistan
Controlling bacterial infections responsible for typhoid fever could dramatically reduce the risk of gallbladder cancer in India and Pakistan, according to Cell Host & Microbe study. The findings establish the causal link between bacterial infection and gallbladder cancer, explaining why this type of cancer is rare in the West but common in India and Pakistan, where typhoid fever is endemic. Public policy changes inspired by this research could have an immediate impact.

Contact: Joseph Caputo
jcaputo@cell.com
617-335-6270
Cell Press

Public Release: 27-May-2015
Genome Medicine
New online tool to predict genetic resistance to tuberculosis drugs
A new TB-Profiler tool, developed by scientists at the London School of Hygiene & Tropical Medicine, analyses and interprets genome sequence data to predict resistance to 11 drugs used for the treatment of TB. This rapid tool means that sequence data can now be used without delay, so that finding which drugs to use for a patient with TB can be sped up by days or even weeks; increasing the likelihood of a cure.

Contact: Katie Steels
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Public Release: 27-May-2015
PLOS ONE
Study in Nigeria finds 1 in 10 malaria drugs are poor quality
A rigorous analysis of more than 3,000 antimalarials purchased in Nigeria found 9.3 percent to be of poor quality, according to new research from the London School of Hygiene & Tropical Medicine.
Bill & Melinda Gates Foundation

Contact: Katie Steels
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Showing releases 101-125 out of 1084.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>